JCOG1407: Randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2019
This article has no abstract
Epistemonikos ID: e16d22557748cb2c244e0e3417f1dded30ab0f98
First added on: Mar 11, 2025